Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP854477.RA4MHLjPxPflBS7XslaAlxaQgV4Yqv5_6DnCDrwbP1Mlk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP854477.RA4MHLjPxPflBS7XslaAlxaQgV4Yqv5_6DnCDrwbP1Mlk130_assertion type Assertion NP854477.RA4MHLjPxPflBS7XslaAlxaQgV4Yqv5_6DnCDrwbP1Mlk130_head.
- NP854477.RA4MHLjPxPflBS7XslaAlxaQgV4Yqv5_6DnCDrwbP1Mlk130_assertion description "[Hallmarks of MS pathology were confirmed by messenger RNA expression patterns of glial fibrillary acidic protein, neurofilament (NF), myelin basic protein, growth factors, chemokines and receptors, and macrophage activation markers, although expression of osteopontin and alphaB-crystallin was decreased.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP854477.RA4MHLjPxPflBS7XslaAlxaQgV4Yqv5_6DnCDrwbP1Mlk130_provenance.
- NP854477.RA4MHLjPxPflBS7XslaAlxaQgV4Yqv5_6DnCDrwbP1Mlk130_assertion evidence source_evidence_literature NP854477.RA4MHLjPxPflBS7XslaAlxaQgV4Yqv5_6DnCDrwbP1Mlk130_provenance.
- NP854477.RA4MHLjPxPflBS7XslaAlxaQgV4Yqv5_6DnCDrwbP1Mlk130_assertion SIO_000772 17879969 NP854477.RA4MHLjPxPflBS7XslaAlxaQgV4Yqv5_6DnCDrwbP1Mlk130_provenance.
- NP854477.RA4MHLjPxPflBS7XslaAlxaQgV4Yqv5_6DnCDrwbP1Mlk130_assertion wasDerivedFrom befree-20140225 NP854477.RA4MHLjPxPflBS7XslaAlxaQgV4Yqv5_6DnCDrwbP1Mlk130_provenance.
- NP854477.RA4MHLjPxPflBS7XslaAlxaQgV4Yqv5_6DnCDrwbP1Mlk130_assertion wasGeneratedBy ECO_0000203 NP854477.RA4MHLjPxPflBS7XslaAlxaQgV4Yqv5_6DnCDrwbP1Mlk130_provenance.